Эффективность и безопасность послеоперационной аналгезии кеторолаком и трамадолом в зависимости от наличия полиморфизмов CYP2D6 и CYP2C9

1. Ladak SSJ, Chan VWS, Easty T, Chagpar A. Right medication, right dose, right patient, right time, and right route: how do we select the right patient-controlled analgesia (PCA) device? Pain Manag Nurs. 2007;8(4):140-5. DOI: 10.1016/j.pmn.2007.08.001.

2. Kukes VG, Sychev DA, Ramenskaya GV, Ignat’ev IV. Pharmacogenetics of system of biotransformation and drugs transporters: from the theory to practice. Biomeditsina. 2007;6:29-47. (In Russ).

3. Ko TM, Wong CS, Wu JY, Chen YT. Pharmacogenomics for personalized pain medicine. Acta Anaesthesiol. Taiwan. 2016;54(1):24-30. DOI: 10.1016/j.aat.2016.02.001.

4. Crews KR, Hicks JK, Pui CH et al. Pharmacogenomics and individualized medicine: translating science into practice. Clin Pharmacol Ther. 2012;92(4):467-75. DOI: 10.1038/clpt.2012.120.

5. Tomalik-Scharte D, Lazar A, Fuhr U, Kirchheiner J. The clinical role of genetic polymorphisms in drug-metabolizing enzymes. Pharmacogenomics J. 2008;8(1):4-15. DOI: 10.1038/sj.tpj.6500462.